A new vaccine developed by CSIRO Livestock Industries to help control the common poultry disease, fowlpox, has been registered for commercial use by one of Australia’s leading animal health companies, Intervet Australia Pty Ltd.

In a world first, a team of international scientists led by CSIRO has constructed a virtual map of the genome of the sheep.

The world’s first commercial DNA test for beef cattle feed efficiency was launched at the Australian Lot Feeders Association’s annual conference on the Gold Coast last week.

Research partnerships such as those at the Queensland Bioscience Precinct will provide solutions to the major problems facing the nation and the world.

CSIRO is working to integrate a number of scientific approaches -  with a focus on gene products -  to identify genes or gene pathways of commercial importance that can be manipulated at the molecular level.

CSIRO’s Mitigation of disease impact through modification of the host response research aims to develop novel strategies and products to limit the spread of major animal diseases.

CSIRO researchers are using quantative and molecular genetic techniques to boost the performance and profitability of Australia’s livestock industries.

CSIRO is a partner in the international consortium that has sequenced the bovine genome making the cow the first ruminant mammal to have its genome sequenced.

This two-page information sheet details how CSIRO is investigating gene silencing as a way to stop the spread of avian influenza.

A three-page article by CSIRO Livestock Industries providing in-depth information on our research aimed at protecting poultry from avian influenza and how CSIRO scientists are exploring gene silencing as a means to this end.